Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: "Residents of some Baltimore neighborhoods are no better off than people living in impoverished North Korea and the violent West Bank, Bernie Sanders said during a campaign rally in Maryland ahead of that state’s primary. ""Poverty in Baltimore, and around this country — poverty is a death sentence,"" Sanders said April 24. He then laid out some rather unflattering and harsh comparisons: ""Fifteen neighborhoods in Baltimore have lower life expectancies than North Korea. Two of them have a higher infant mortality rate than the West Bank in Palestine. Baltimore teenagers between the ages of 15 and 19 face poorer health conditions and a worse economic outlook than those in distressed cities in Nigeria, India, China and South Africa. We are talking about the United States of America in the year 2016 — a country in which the top 1/10th of 1 percent now owns almost as much wealth as the bottom 90 percent."" While it would be wrong to take Sanders’ claim to mean that conditions overall are worse than Baltimore, we found that his specific comparisons are largely accurate. ""The comparisons fairly make the point that there are some parts of this rich country where conditions resemble those in much poorer countries,"" said Alan Berube, an expert on urban poverty at the Brookings Institution. ""This isn't isolated to Baltimore; there are neighborhoods in nearly every big U.S. city and metropolitan area, and many rural communities, that perform just as poorly on these outcomes."" Let’s take Sanders’ claims one by one. Life expectancy in North Korea The Sanders campaign referred us to a Washington Post article noting that 14 Baltimore neighborhoods had shorter life expectancies than North Korea in 2013. (The article originally said 15 but was corrected.) His number is slightly outdated. In 2014, the latest year where there’s data on both places, the average life expectancy in North Korea was 69.81 years, according to the CIA World Factbook. That placed the impoverished dictatorship at No. 155 in longest lifespans out of 224 countries. The United States overall ranked at No. 42 with 79.56 years. Residents in 12 of Baltimore's 56 neighborhoods lived shorter lives, according to data from the Baltimore City Health Department provided to the Baltimore Neighborhood Indicators Alliance. That’s not 15, but it’s close. (For context, just five Baltimore neighborhoods have life expectancies higher than the U.S. national average, and four of them are relatively affluent and white.) Here’s a map from the University of Maryland’s Capital News Service that compares the life expectancies of Baltimore neighborhoods in 2013 to other places in the world:  An important caveat: The city of Baltimore has a total population around 600,000 people while North Korea has a population 40 times that. That means fewer events in Baltimore neighborhood could swing the overall life expectancy of a neighborhood up or down. Infant mortality in the West Bank For this claim, the Sanders campaign referred us to a Vox article that said two neighborhoods in Baltimore — Little Italy and Greenmount East — had a higher rate of infant mortality than the West Bank, Honduras and Venezuela in 2013. But in his speech, Sanders only mentioned the West Bank. In 2014, 13.49 out of 1,000 babies died before their first birthday in the notorious conflict zone, according to the CIA’s World Factbook. The West Bank places in the middle of the pack in infant mortality at No. 117 out of 224 countries. The United States, meanwhile, ranked at No. 169 with a rate of 6.17 deaths per 1,000. In 2014, 11 Baltimore neighborhoods had a higher rate than the West Bank. In Hilltop and Little Italy, at least 20 out of 1,000 infants died before their first birthday. That’s not only higher than the West Bank, Honduras and Venezuela but also war-torn Syria and oppressive Uzbekistan. Teen health in distressed cities in developing countries Sanders claimed that ""Baltimore teenagers between the ages of 15 and 19 face poorer health conditions and a worse economic outlook than those in distressed cities in Nigeria, India, China and South Africa."" The Sanders campaign cited a Washington Post article by Johns Hopkins University researchers. ""Teenagers in Baltimore face poorer health and more negative outlooks than those in urban centers of Nigeria, India and China,"" they write. Contrary to what Sanders said, the work by the Johns Hopkins researchers don’t consider economic outlooks nor do they show Baltimore conditions being worse than South Africa’s. Nonetheless, his broader point is accurate. The researchers published a comprehensive set of studies published in the Journal of Adolescent Health in 2014 that compared the well-being of teens in impoverished areas in Baltimore; Ibadan, Nigeria; Johannesburg, South Africa; New Delhi, India; and Shanghai, China. Baltimore teens reported the highest rates pregnancy and, after Johannesburg, the second highest rates of substance use, sexual and physical violence, and feeling unsafe in their community:  Our ruling Sanders presented a series of comparisons showing that conditions in some parts of Baltimore rivaled that of ""the West Bank in Palestine,"" ""North Korea,"" and ""distressed cities in Nigeria, India, China and South Africa. Some of Sanders’ figures need to be updated, but the gist of his specific comparisons are accurate: 12 Baltimore neighborhoods have a lower life expectancy than North Korea; 11 have a higher infant mortality rate than the West Bank; and research shows health conditions are worse for poor teens than in Baltimore than in Ibadan, New Delhi and Shanghai." Claim: "Bernie Sanders Says an array of statistics show that conditions in some parts of Baltimore rival that of ""the West Bank in Palestine,"" ""North Korea,"" and ""distressed cities in Nigeria, India, China and South Africa."
[EX A]: "Sanders presented a series of comparisons showing that conditions in some parts of Baltimore rivaled that of ""the West Bank in Palestine,"" ""North Korea,"" and ""distressed cities in Nigeria, India, China and South Africa. Some of Sanders’ figures need to be updated, but the gist of his specific comparisons are accurate: 12 Baltimore neighborhoods have a lower life expectancy than North Korea; 11 have a higher infant mortality rate than the West Bank; and research shows health conditions are worse for poor teens than in Baltimore than in Ibadan, New Delhi and Shanghai."

[EX Q]: Paragraph: Pfizer shares were up nearly 4 percent on positive findings for the oral treatment, called palbociclib, one of the company’s most important experimental drugs that some analysts believe could eventually claim annual sales of more than $5 billion, if approved. The trial tested the pill in post-menopausal patients with locally advanced or newly diagnosed breast cancer that had spread to other parts of the body. “We are delighted with the final data,” Pfizer said in a release, adding the company will discuss the successful data on progression-free survival with the U.S. Food and Drug Administration “to determine next steps” for palbociclib. A secondary goal of the study is to determine whether palbociclib can prolong overall survival. But Pfizer spokeswoman Sally Beatty said the company does not yet have such data, because it takes longer periods to follow patients and gauge survival trends. Although Pfizer is conducting two larger late-stage trials of palbociclib, ISI Group analyst Mark Schoenebaum noted the company has previously said it might discuss with the FDA the potential to seek approval of the medicine based upon mid-stage trial data, if the data warranted. Palbociclib, which blocks enzymes known as cyclin-dependent kinases (CDKs) 4 and 6, was taken in combination with a standard treatment called letrozole among women who were estrogen receptor positive - meaning tumors grow in response to estrogen - and HER2-negative, meaning that the HER2 protein is not causing the cancer. Such patients make up about 60 percent of advanced breast cancer cases. Letrozole is the chemical name of Femara, a Novartis AG drug that belongs to a class of treatments called aromatase inhibitors that block production of estrogen. Pfizer on Monday did not present detailed data from the trial results, saying they would be presented at a scientific meeting in San Diego in April. The success of the trial, called Paloma-1, follows highly favorable interim data that Pfizer unveiled in December 2012. At that point in the study, those taking both palbociclib and letrozole went an average of 26.1 months before tumors worsened. That compared with 7.5 months for those taking letrozole, but not palbociclib. The 18.6-month difference was considered statistically significant. Side effects from palbociclib were similar to those previously reported, Pfizer said on Monday. The earlier interim results had shown that patients taking the drug combination experienced anemia, fatigue and neutropenia - a decline in white blood cells called neutrophils that can put patients at higher risk of infection. Palbociclib was designated a “breakthrough” drug by the FDA last April based on initial data from the trial. The FDA grants “breakthrough” status to drugs that may offer substantial improvement over existing treatments for serious or life-threatening diseases. The status helps to speed up the approval process. Pfizer has started two late-stage trials of the drug - Paloma-2 and Paloma-3 - in patients with advanced breast cancer. Paloma-2 will test the same drug combination, palbociclib and letrozole, as an initial treatment for breast cancer. Paloma-3 will evaluate palbociclib in combination with another hormone therapy, fulvestrant, in women whose cancer has progressed after hormonal therapy. The drug, sold under the brand name Faslodex by AstraZeneca Plc, is called an estrogen receptor antagonist. Companies trying to develop treatments similar to palbociclib include Novartis and Eli Lilly & Co. Breast cancer killed more than 508,000 women worldwide in 2011, according to the World Health Organization. Pfizer shares were up 3.7 percent at $31.53 on Monday morning on the New York Stock Exchange. Claim: Pfizer breast cancer drug succeeds in mid-stage trial.
[EX A]: Pfizer Inc’s experimental breast cancer drug significantly delayed progression of symptoms in a mid-stage trial, meeting the study’s primary goal and keeping Pfizer in the forefront of a race for a new standard of care for the disease.

[EX Q]: Paragraph: In July 2020, media outlets reported that a squirrel in Colorado tested positive for bubonic plague, making it the first case of plague in Jefferson County. This claim is true, though experts caution that the incident is not cause for immediate concern. “On Saturday, July 11, 2020, a squirrel found in the Town of Morrison tested positive for bubonic plague. The squirrel is the first case of plague in the county,” wrote the Jefferson County Public Health Department in a press release. It is not immediately clear what prompted the investigation into the dead squirrel and no further incidents of other animal or human infection were reported at the time of publication. NOTICE: On Saturday, July 11, a squirrel found in the Town of Morrison tested positive for bubonic plague. The squirrel is the first case of plague in the county. Read more: https://t.co/Ernd8QYrgA — Jefferson County Public Health (@JeffcoPH) July 12, 2020 Claim: A squirrel in a rural Colorado town tested positive for bubonic plague in July 2020.
[EX A]:
The Centers for Disease Control and Prevention (CDC) reported that recent decades have seen an average of around seven human plague cases in the U.S. each year that typically occur in rural areas, most commonly in the southwestern states. Globally, between 1,000 and 2,000 people will be diagnosed with plague each year, yet health experts argue that there is still little cause for concern. Snopes contacted the CDC for comment but has not received a response at the time of publication.